NCT00002042View on ClinicalTrials.gov

A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV InfectionsCytopenias
Interventions
DRUG

Epoetin alfa

Trial Locations (1)

088690602

Ortho Pharmaceutical Corp, Raritan

Sponsors
All Listed Sponsors
lead

Ortho Pharmaceuticals

INDUSTRY

NCT00002042 - A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With Anemia | Biotech Hunter | Biotech Hunter